Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics

Researchers from the Shanghai Jiao Tong University in China have found that metformin treatment lowers the risk of colorectal cancer in patients with type two diabetes, according to a news release.

Advertisement
By: Staff

The researchers analyzed five studies from Jan. 1966-Mar. 2011, which consisted of 108,161 participants, to look for links between metformin and colon cancer incidence. The analysis revealed a 37 percent decrease in risk.

Related Articles about Colon Cancer:
Demographic Data Helps Determine Colon Cancer Risk
Bloodstream Infections Linked to Colorectal Cancer
Women Can Wait Longer Than Men to Start Colonoscopies, Study Finds

Healthcare learning reimagined: How AI is reshaping the education + compliance landscape

Recommended OnDemand Webinar

Advertisement

Next Up in GI & Endoscopy

  • Is high acuity the new normal in GI?

    As colonoscopy demand rises, driven in part by more diagnostic referrals for patients under 55, GI leaders are also seeing…

    By: Patsy Newitt

  • ConMed to end its GI product lines

    Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected…

    By: Cameron Cortigiano
Advertisement

Comments are closed.